Clinical Trials Browser

Phase 4 × icotinib × Clear all

NCT02744664 2020-05-27

Cryotherapy Combine Icotinib for Advanced NSCLC Treatment

Phase 4 Completed

Lung Neoplasms

NCT02404675 2017-07-28

INCREASE

Phase 4 Unknown

NSCLC

NCT02778893 2016-05-20

Conmana Combined With Thalidomide to Treat NSCLC

Phase 4 Unknown

NSCLC

NCT02031601 2016-03-29

TCL-1

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01646450 2015-09-09

First-line Treatment With Icotinib in Elder NSCLC EGFR Mutated Patients

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01926171 2015-07-15

Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01720901 2015-05-22

Increased Dose of Icotinib in Advanced None Small Cell Lung Cancer Patients After Routine Gefitinib Therapy

Phase 4 Suspended

Carcinoma, Non-Small-Cell Lung

NCT02103257 2015-04-29

Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma

Phase 4 Unknown

Adenocarcinoma

NCT02283424 2014-11-05

Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation

Phase 4 Unknown

Neoplasms, Second Primary

NCT01465243 2014-02-17

Dose Escalation Of Icotinib In Previously Treated Patients With Routine Dose

Phase 4 Completed

Carcinoma, Non-Small-Cell Lung